Gadolinium Enhanced Magnetic Resonance Urography for Upper Urinary Tract Malignancy

Journal of Urology

Volumn 183, Issue 4, 2010, Pages 1330-1336

  Takahashi, Naoki ^a   Glockner, James F ^a   Hartman, Robert P ^a   King, Bernard F ^a   Leibovich, Bradley C ^a   Stanley, David W ^b   Fitz Gibbon, Patrick D ^a   Kawashima, Akira ^a  

^a MAYO CLINIC   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

carcinoma; contrast media; diagnosis; magnetic resonance imaging; urinary tract

Indexed keywords

FAT; FUROSEMIDE; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM;

AGED; ARTICLE; BREATH HOLDING; CALCULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; INJECTION; KIDNEY CANCER; KIDNEY COLLECTING TUBULE; MAGNETIC RESONANCE UROGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; RENOGRAPHY; RETROSPECTIVE STUDY; URETER CANCER; URINARY TRACT CANCER; UROGRAPHY; UROTHELIAL CARCINOMA;

AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; URETERAL NEOPLASMS; UROGRAPHY;

EID: 77949305580     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.031     Document Type: Article

References (30)

1. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594
2. Kirkali Z., and Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47 (2003) 155
3. Grossfeld G.D., Litwin M.S., Wolf Jr. J.S., et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57 (2001) 604
4. Grossfeld G.D., Litwin M.S., Wolf J.S., et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part I: definition, detection, prevalence, and etiology. Urology 57 (2001) 599
5. Caoili E.M., Cohan R.H., Inampudi P., et al. MDCT urography of upper tract urothelial neoplasms. AJR Am J Roentgenol 184 (2005) 1873
6. Fritz G.A., Schoellnast H., Deutschmann H.A., et al. Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract. Eur Radiol 16 (2006) 1244
7. Aerts P., Van Hoe L., Bosmans H., et al. Breath-hold MR urography using the HASTE technique. AJR Am J Roentgenol 166 (1996) 543
8. Regan F., Bohlman M.E., Khazan R., et al. MR urography using HASTE imaging in the assessment of ureteric obstruction. AJR Am J Roentgenol 167 (1996) 1115
9. Tang Y., Yamashita Y., Namimoto T., et al. The value of MR urography that uses HASTE sequences to reveal urinary tract disorders. AJR Am J Roentgenol 167 (1996) 1497
10. Sudah M., Vanninen R., Partanen K., et al. MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography. Fast low-angle shot. AJR Am J Roentgenol 176 (2001) 105
11. Chahal R., Taylor K., Eardley I., et al. Patients at high risk for upper tract urothelial cancer: evaluation of hydronephrosis using high resolution magnetic resonance urography. J Urol 174 (2005) 478
12. Leyendecker J.R., Barnes C.E., and Zagoria R.J. MR urography: techniques and clinical applications. Radiographics 28 (2008) 23
13. Nolte-Ernsting C.C., Bucker A., Adam G.B., et al. Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography. Radiology 209 (1998) 147
14. Takahashi N., Kawashima A., Glockner J.F., et al. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology 247 (2008) 451
15. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman, New York
16. Jung P., Brauers A., Nolte-Ernsting C.A., et al. Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int 86 (2000) 960
17. Shokeir A.A., El-Diasty T., Eassa W., et al. Diagnosis of noncalcareous hydronephrosis: role of magnetic resonance urography and noncontrast computed tomography. Urology 63 (2004) 225
18. Takahashi N., Kawashima A., Glockner J.F., et al. MR urography for suspected upper tract urothelial carcinoma. Eur Radiol 19 (2009) 912
19. Chow L.C., Kwan S.W., Olcott E.W., et al. Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement. AJR Am J Roentgenol 189 (2007) 314
20. Cowan N.C., Turney B.W., Taylor N.J., et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int 99 (2007) 1363
21. Wang L.J., Wong Y.C., Chuang C.K., et al. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181 (2009) 524
22. Sudakoff G.S., Dunn D.P., Guralnick M.L., et al. Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol 179 (2008) 862
23. Kuo P.H., Kanal E., Abu-Alfa A.K., et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242 (2007) 647
24. Broome D.R., Girguis M.S., Baron P.W., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188 (2007) 586
25. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 (2007) 148
26. Prince M.R., Zhang H., Morris M., et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248 (2008) 807
27. Wertman R., Altun E., Martin D.R., et al. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 248 (2008) 799
28. Silverman S.G., Leyendecker J.R., and Amis Jr. E.S. What is the current role of CT urography and MR urography in the evaluation of the urinary tract?. Radiology 250 (2009) 309
29. Weinreb J.C. Which study when?. Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT?. Radiology 249 (2008) 3
30. Morcos S.K. Extracellular gadolinium contrast agents: differences in stability. Eur J Radiol 66 (2008) 175